Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F91ZM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,241
Award facts
- Contract value 100% obligated
- $34,241.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34.2K delivery order to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. The contract, awarded on February 4, 2026, with an ultimate completion date of February 5, 2026, represents a firm fixed-price purchase under a non-set-aside competitive procurement. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company routinely fulfills delivery orders for an extensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This contract award exemplifies the company's role in supplying essential pharmaceutical commodities to the Defense Health Agency and other federal healthcare systems through the comprehensive DLA Troop Support Medical contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F91ZM?
SPE2DR26F91ZM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F91ZM worth?
The government has obligated $34,241 on SPE2DR26F91ZM.
Is contract SPE2DR26F91ZM an order under another contract?
Yes. SPE2DR26F91ZM is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91ZM competed?
The extent of competition for SPE2DR26F91ZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award